# Efficacy of Ventavis Used in Real-life Setting.

> **NCT01355380** · — · COMPLETED · sponsor: **Bayer** · enrollment: 55 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** Inhaled iloprost (Ventavis, BAYQ6256)

## Key facts

- **NCT ID:** NCT01355380
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08-05
- **Primary completion:** 2016-04-28
- **Final completion:** 2016-09-22
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2017-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01355380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01355380, "Efficacy of Ventavis Used in Real-life Setting.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01355380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*